Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/21/2009 | CN100551410C Antidepressive medicine and its preparation method |
10/21/2009 | CN100551404C Preparing method for composition of medication for inducing diuresis to alleviate edema, detection method and usage |
10/21/2009 | CN100551403C Medicine for treating chronic nephritis and its preparing process |
10/21/2009 | CN100551402C Chinese medicinal composition for treating disease of mammary glands and preparation method thereof |
10/21/2009 | CN100551401C Chinese-medicinal composition for treating osmidrosis |
10/21/2009 | CN100551398C Capsule for clearing lung heat to relieve cough |
10/21/2009 | CN100551393C Honey polygala root and its preparation method |
10/21/2009 | CN100551392C Decumbent corydalis Rhizome medicinal composition for treating cerebral thrombosis sequela and rheumatic arthritis |
10/21/2009 | CN100551391C A medicine for preventing and treating diabetes, preparation method and application thereof |
10/21/2009 | CN100551389C Medicine for treating early bone tumor |
10/21/2009 | CN100551388C An injection containing phenylpropanolid glycosides, its preparation method and use |
10/21/2009 | CN100551386C Dry coating sustained-release tablet for treating arthritis and preparation process thereof |
10/21/2009 | CN100551385C Externally used traditional Chinese medicine and its preparing process |
10/21/2009 | CN100551384C Plaster for treating hyperosteogeny, neuro-pain and various kinds of inflammation |
10/21/2009 | CN100551383C Chinese medicine preparation for treating heart disease |
10/21/2009 | CN100551380C Bacteriostat-free water-soluble vitamin freeze-dried preparation for injection |
10/21/2009 | CN100551378C Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
10/21/2009 | CN100551377C Bisphosphonic acid for the treatment and prevention of osteoporosis |
10/21/2009 | CN100551376C Antibiotic slow-release preparation for local use |
10/21/2009 | CN100551374C Sterilization technology of prostadil fatty emulsion and method of determination |
10/21/2009 | CN100551373C Buspirone hydrochloride slow/controlled release micro pill |
10/21/2009 | CN100551371C Zirasitone mesylate soluble medicinal preparation |
10/21/2009 | CN100551370C Use of Ranolazine in preparing pharmaceutical composition for treating diabetes |
10/21/2009 | CN100551369C Sustained release preparation containing cilostazol and its preparation method |
10/21/2009 | CN100551368C Ciclopirox olamine gelling agent, method for preparing the same and pharmaceutical use thereof |
10/21/2009 | CN100551367C Use of chloride 13-hexyl berberine and chloride 13-hexyl palmatine in preparation of medicine for treating vagina infection-inflammation |
10/21/2009 | CN100551366C Use of atractylone in preparing influenza virus resisting medicine |
10/21/2009 | CN100551365C Method for preparing submicron particles of taxol |
10/21/2009 | CN100551363C A solid dosage form comprising a fibrate |
10/21/2009 | CN100551362C Shuanghuanglian effervescence tablet and preparation thereof |
10/21/2009 | CN100551361C Defervesce effervescence tablet for treating cold and preparation method thereof |
10/21/2009 | CN100551360C Radix Isatidis effervescence tablet and preparation method thereof |
10/21/2009 | CN100551359C Red medicine thin film coating tablet |
10/21/2009 | CN100551358C Method for making particles for use in a pharmaceutical composition |
10/21/2009 | CN100551357C Anti-fatigue medicine prepared from coriolus versicolor mycelium |
10/21/2009 | CN100551356C Membrane production technology of spirit-quieting brain-replenishing liquid and its product |
10/21/2009 | CN100551355C Compound three-segment plug of hydrochloric acid amodiaquine and artesunate |
10/21/2009 | CN100551345C Stable topical drug delivery compositions |
10/21/2009 | CN100551267C Selenium and zinc enriched health food and preparation process thereof |
10/20/2009 | US7605328 Photovoltaic thin-film cell produced from metallic blend using high-temperature printing |
10/20/2009 | US7605249 To deliver specifically tailored small interfering RNA as therapeutic agents for treatment of Parkinson's disease |
10/20/2009 | US7605231 Having organic compound as graft chain and high-molecular weight micelle containing the gelatin derivative; as organic compound, a low molecular weight compound such as succinic acid, ethylenediamine, or high-molecular weight compound such as polyethylene glycol can be used; adhesion preventing membrane |
10/20/2009 | US7605173 Pharmaceutical liquid composition containing pyridone derivative |
10/20/2009 | US7605141 Preserving vitamins subject to oxidative damage by adding a sufficient amount of purified nucleic acid to vitamin such that the rate of oxidative damage of the vitamin is reduced |
10/20/2009 | US7605138 Nucleic acid compositions for stimulating immune responses |
10/20/2009 | US7605124 an ejection liquid for stably ejecting a solution containing at least one kind of insulin ( polyoxyethylene glycol or polyvinyl alcohol modified insulin), citric acid and a surfactant; ejecting the liquid by a thermal inkjet system |
10/20/2009 | US7605121 Oligopeptide lyophilisate, their preparation and use |
10/20/2009 | US7604973 Lyases; bactericides; gene knockout; animal husbandry; use of nucleic acid segment in the preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product |
10/20/2009 | US7604933 Enriched with oxygen and comprises base nutritive medium and liposomes comprising cholesterol; biopsies; freezing; drug screening |
10/20/2009 | US7604822 Injectable solution with anti-inflammatory effect and process for manufacturing the same |
10/20/2009 | US7604820 A sustained release, colonic delivery solid preparation taken by mounth comprising a drug and excipient coated by awater-soluble film of a chitosan powder dispersed in ethyl cellulose or an ethyl acrylate-methylmethacrylate or cationic acrylate polymer thereof; side effect reduction; enteric coatings |
10/20/2009 | US7604819 A device capable of providing a hemostatic effect on bleeding comprises a clay disposed on a gauze substrate; a water-soluble polyol binder to bind the clay material to the gauze and suppress clay dust; clay assists inaccelerating coagulation; flexibiity; shapeing;henostatic agents; surgery; bandages |
10/20/2009 | US7604816 Bio-absorbable collagen-based wound dressing |
10/20/2009 | US7604811 Inducing an immune response in mammals comprising administering an antigenic synthetic peptide containing Colonization FactorAntigen/I pilus protein T-cell epitopes encapsulated within a biodegradable matrix of glycolic acid-lactic acid copolymer; amino acid sequences; intestinal bioavailability |
10/20/2009 | US7604803 Codelivery to a cell of nucleic acid and assistor protein (antigen) where the nucleic acid encodes an antigenic protein or which shares an epitope(s) with the assistor protein; the nucleic acid is entrapped in liposome intravesicular space; assistor protein is on the liposome surface; synergistic |
10/20/2009 | US7604668 Composite self-cohered web materials |
10/20/2009 | US7604629 Multi-parameter infection monitoring |
10/20/2009 | US7604628 Multi-cap reservoir devices for controlled release or exposure of reservoir contents |
10/20/2009 | US7604185 Generation of therapeutic microfoam |
10/20/2009 | CA2531833C Poly-4-hydroxybutyrate matrices for sustained drug delivery |
10/20/2009 | CA2492854C Sustained-release tablet composition of pramipexole |
10/20/2009 | CA2481593C Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin |
10/20/2009 | CA2446712C System for osmotic delivery of pharmaceutically active agents |
10/20/2009 | CA2413088C Preservative |
10/20/2009 | CA2402267C Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails |
10/20/2009 | CA2389349C Aerosol composition comprising formoterol |
10/20/2009 | CA2376226C New formulation |
10/20/2009 | CA2360110C Sustained release salts of pharmaceutically active peptides and their production |
10/20/2009 | CA2339482C Composite hydrogel drug delivery systems |
10/20/2009 | CA2330183C Novel insulin analogs with enhanced zinc binding |
10/20/2009 | CA2306214C Plaster for topical use containing heparin and diclofenac |
10/20/2009 | CA2290743C Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering |
10/20/2009 | CA2274358C Hydrophilic adhesive masses |
10/18/2009 | CA2662943A1 Inhalative and instillative use of semifluorinated alkanes as an active substance carrier in the intrapulmonary area |
10/15/2009 | WO2009126938A1 Nanoparticle formulations and uses thereof |
10/15/2009 | WO2009126926A2 Anticancer methods employing extracts of gleditsia sinensis lam |
10/15/2009 | WO2009126913A1 Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery |
10/15/2009 | WO2009126835A2 Magnetic nanoparticle and method for imaging t cells |
10/15/2009 | WO2009126805A2 Therapeutic tarageting of mmps in neutral liposomes |
10/15/2009 | WO2009126764A1 Methods and use of inducing apoptosis in cancer cells |
10/15/2009 | WO2009126742A2 Enzyme mediated delivery system |
10/15/2009 | WO2009126738A2 Dried formulations |
10/15/2009 | WO2009126720A1 Fluid control device having a safety needle |
10/15/2009 | WO2009126513A1 Colchicine solid complex; methods of making; and methods of use thereof |
10/15/2009 | WO2009126442A1 Compositions and methods for composite nanoparticle hydrogels |
10/15/2009 | WO2009126401A1 Compositions of hydrophobic taxane derivatives and uses thereof |
10/15/2009 | WO2009126302A2 Stabilized oleosome preparations and methods of making them |
10/15/2009 | WO2009126301A2 Controlled release of active agents from oleosomes |
10/15/2009 | WO2009126211A2 Controlled release formulation of water insoluble drug and methods of preparation and treatment |
10/15/2009 | WO2009126175A1 Compositions of hydrophobic taxane derivatives and uses thereof |
10/15/2009 | WO2009126145A1 Phosphate-binding chitosan and uses thereof |
10/15/2009 | WO2009126014A1 Cell receptor blocker for preventing and treating avian influenza and other diseases caused by viruses |
10/15/2009 | WO2009125987A2 Pharmaceutical formulation |
10/15/2009 | WO2009125981A2 Pharmaceutical formulation |
10/15/2009 | WO2009125975A2 Combination of mitiglinide and metformin and process for preparing same |
10/15/2009 | WO2009125944A2 Pharmaceutical preparation containing non-dihydropyridine calcium channel blocker and angiotensin-2 receptor blocker |
10/15/2009 | WO2009125858A1 Lipid dispersion preparation comprising 2-indolinone derivative |
10/15/2009 | WO2009125816A1 Vesicle and cosmetic containing the same |
10/15/2009 | WO2009125667A1 Water-based adhesive skin patch containing butenafine hydrochloride |
10/15/2009 | WO2009125485A1 Hard capsule |